Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?

Luca Bertolaccini; Lorenzo Spaggiari

doi:10.3390/cancers15071993

Is It Time to Cross the Pillars of Evidence in Favor of Segmentectomies in Early-Stage Non-Small Cell Lung Cancer?

Cancers (Basel). 2023 Mar 27;15(7):1993. doi: 10.3390/cancers15071993.

Authors

Luca Bertolaccini¹, Lorenzo Spaggiari^{1

2}

Affiliations

¹ Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
² Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Abstract

In the debate on lobectomy versus segmentectomy for the treatment of early-stage non-small cell lung cancer (NSCLC), currently, we have reached two pillars of knowledge, like Jachim and Boaz, which have encompassed the actual boundary of the literature published up until now [...].

Keywords: lobectomy; lung cancer; randomized controlled trial; segmentectomy.

Publication types

Editorial

Abstract

Publication types

Grants and funding